MedTrace Logo

Engineering Evaluation of an Eye Movement Monitor Device

NCT05222022 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 39

Last updated 2024-02-23

No results posted yet for this study

Summary

The objective of the engineering evaluation is to verify and validate the design of an eye movement monitor device, the Retitrack, for recording, viewing, measuring, and analyzing temporal characteristics of fixation and saccadic responses in human eyes when viewing a visual stimulus.

This engineering evaluation is not an applicable clinical trial. This is a design validation of the mechanism of action of the device to measure eye movement. This is not a clinical trial to evaluate the effect of an intervention on biomedical or other health-related outcomes.

Conditions

  • Healthy

Interventions

DEVICE

Retitrack

Retitrack device measures and analyzes eye movement

Sponsors & Collaborators

  • C. Light Technologies, Inc.

    lead INDUSTRY

Principal Investigators

  • Jacqueline Theis, OD · Concussion Care Centre of Virginia, Ltd.

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-02-18
Primary Completion
2023-05-31
Completion
2023-10-10
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05222022 on ClinicalTrials.gov